医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2021年欧洲肺癌大会
     
 
 

◆ 会议时间:2021年3月25-27日
◆ 会议地点:虚拟会议

 

◆ 会议简介:

2021年欧洲肺癌大会(ELCC2021)-虚拟会议将于2021年3月25-27日举行,会议由欧洲肿瘤内科学会(ESMO)与国际肺癌研究协会(IASLC)联合组织。ELCC由代表胸部肿瘤专家的最重要的多学科学会联合协作举办,以促进科学发展、传播教育和提高全世界肺癌专家的实践。领域国际医学会议网;回顾当前肺癌治疗的最新技术,更新您在预防、筛查、检测等方面的知识,与会者将从其全面而令人振奋的科学计划中受益。自2008年首次举办以来,ELCC已成为该领域专业人士的首要会议,大会与会者包括肿瘤内科医师、放射肿瘤学家、胸外科医生、呼吸内科医师/肺科医师、介入放射科医师、病理学家等众多专家学者。2021年欧洲肺癌大会(ELCC2021)预计有超过2000名专业人士与会。

国际肺癌研究协会(IASLC)成立于1974年,是全球唯一致力于肺癌研究的组织,由致力于肺癌领域研究的专家们发起和创立,成员包括来自于全球100多个国家的5000多名肺癌专家。IASLC在肺癌和其他胸部恶性肿瘤的病因学、流行病学、预防、诊断、治疗以及与之相关的领域开展深入研究,为医学团体与大众服务。

欧洲肿瘤内科学会(ESMO)成立于1975年,是欧洲领先的肿瘤内科学专业组织,现在全球150多个国家和地区拥有超过17,000名会员,是肿瘤学教育和信息的参考学会,ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织,ESMO一直以推动癌症护理和治疗为使命,致力于推进肿瘤医学专业的发展,以多学科的方法来促进癌症的治疗和护理。—领域国际医学会议网翻译整理,未经本站允许,禁止复制、转载本站任何内容。

The European Lung Cancer Congress (ELCC) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme.

 

Abstract submission deadlines

Deadline

Date and time

Abstract 

Trial in Progress

Intent to submit LBA

Tuesday, 12 January 2021, 21:00 CET (Central European Time)

Late-breaking abstracts (LBA)

Tuesday, 16 February 2021, 21:00 CET (Central European Time)

点此提交摘要>>>Submit Abstract>>>

Submission categories

  • Tumour biology and pathology
  • Translational research
  • Prevention, early detection, epidemiology, tobacco control
  • Imaging and staging
  • SCLC
  • Early stage NSCLC
  • Locally advanced NSCLC
  • Advanced NSCLC
  • Metastases to and from the lung
  • Mesothelioma
  • General interest

Late-breaking abstracts (LBA) 

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.  

Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 12 January 2021 will be considered for late-breaking status. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to the ELCC 2021.

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on of Tuesday, 12 January 2021.   

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by Tuesday, 16 February 2021

Trial in progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2021

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design
Notes:
  • Recruitment must have already begun or have been completed by the abstract submission deadline of 12 January 2021.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts will not be considered for Proffered Paper (oral) presentation or Mini Oral.
  • Encore TiP abstracts will NOT be accepted. 

Presentation options for accepted abstracts 

The ELCC 2021 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral – Short presentation by authors with comment and interactive audience discussion led by an invited expert.
  • E-poster – Display session for presentation, review, and questions.

All accepted abstracts will be published in the ELCC 2021 Abstract book, a supplement to the official ESMO journal, Annals of Oncology.

 

注册费:

The ELCC Virtual Congress offers

  • Live streaming of sessions
  • Live chat and Q&A
  • Scientific and educational sessions
  • Industry satellite symposia
  • ePosters
  • Virtual exhibition
  • Post-event resources

Registration fees and deadlines 

Registration will remain open for the duration of the virtual congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines. 

Deadlines
(7.7% Swiss VAT included)

Early registration: until 26 February

Full registration:
from 27 February

ESMO Members

Free 

Free

IASLC, ESTRO, ESTS Members

Free 

Free

Non-Members

96.93 EUR 

150.78 EUR

Industry

150.78 EUR

193.86 EUR

 

◆ 参会对象:肿瘤科医师、放射(肿瘤)科医师,胸外科医师,呼吸内科医师,介入放射科医师,病理科医师,护士以及从事肿瘤护理与研究的其他相关专业人士等。

 
 
※相关服务※
会议注册服务:50美金/人/次 + 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1500元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们